Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...
BUFFALO, N.Y. — A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on ...
The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has been increasingly connected to human health and disease. A new Yale study ...
Physical exercise may help reduce inflammation in MS by changing immune activity, a study in mice and patients suggests.
In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...
A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...
A 2-sample Mendelian randomization study found a potential connection between dietary intake and multiple sclerosis (MS) risk and severity. According to the National Multiple Sclerosis Society, diet ...
Overall, people with multiple sclerosis (MS) were not at increased risk of relapse after receiving booster doses of the COVID-19 vaccine, according to a large nationwide study in France. Among over ...
A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on health-related quality of life, with findings that could reshape how services ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results